Covis Pharma, owned by ADVANZ PHARMA Corp is a speciality pharmaceutical company, with a product portfolio addressing medical conditions in the cardiovascular, CNS and acute care markets.In November 2020, Covis Group completed the acquisition of AMAG Pharmaceuticals Inc.In October 2020, Covis signed an agreement to acquire AMAG Pharmaceuticals for approximately $498 million.In March 2015, Concordia Healthcare entered into a definitive agreement to acquire substantially all of the commercial assets of Covis Pharma and Covis Injectables for US $1.2 billion in cash. By that time, the company boards involved had approved the transaction and the acquistion was expected to close in the second quarter of 2015. In April 2015, the acquisition was completed